Abstract:
Obesity is the #1 top risk factor for developing Type 2 Diabetes Mellitus (T2D), and this is the top comorbid condition. The CDC also reports that 35% of the American population in 2023 were diagnosed with Pre-Diabetes Mellitus (PDM) via HbA1c testing and half of that population are also obese (59,500,000 American adults currently have obesity with PDM).1 The purpose of this session is to discuss current research on Integrative Medicine for both obesity and PDM reduction as a side-by-side comparison. Most recently a controlled pilot study for Obesity and PDM Reduction used ALCAT food allergen testing, nutritional counseling, showed a -1.1 BMI reduction and -12% HbA1c reduction in just six months.2 At the same time Metformin is now being accepted standard of care in treating PDM. A previous longitudinal case/control study of food allergen elimination for obesity reduction (N=94) and all therapeutic groups showed a significant change in weight, BMI, BP, and waist circumference (P < 0.0001). A financial post-hoc examination of 20 subjects from the Experimental groups for 12 months beyond that trial revealed a significant financial savings.3 Methods we will discuss the side-by-side treatments for Obesity and PDM reduction as we compare Holistic & Allopathic methods, to examine what the best Integrative treatment plan can be in primary care. The financial savings will be discussed showing that obesity reduction is estimated to save $2,000/year in direct medical expenses and Pre-Diabetes Reduction reverses the pathway to a lifetime of over $80,000 expenses for treating T2D. This session will examine the paired, integrative methods as described in Dr. Willis’ book “LIFE CARE, Integrative Medicine to Improve Your Wellness.”
